Beximco Pharmaceuticals Ltd. (BXPq)

London
Currency in GBP
Disclaimer
40.00
+1.50
(+3.90%)
Closed
High dividend Yield
Day's Range
38.25
40.00
52 wk Range
33.30
72.00
Volume
19,812
Prev. Close
38.5
Open
38.5
Day's Range
38.25-40
52 wk Range
33.3-72
Volume
19,812
Average Volume (3m)
17,768
1-Year Change
-44.06%
Shares Outstanding
446,112,089
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about BXPq?
Vote to see community's results!
or

Beximco Pharmaceuticals Ltd. Company Profile

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Employees
5500

Income Statement